Recent News

• 03.23.2026 - Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease
• 03.05.2026 - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• 02.19.2026 - Insmed Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Business Update
• 02.13.2026 - Insmed To Present at March 2026 Investor Conferences

Recent Filings

• 03.23.2026 - EX-99.1 EX-99.1
• 03.23.2026 - 8-K Current report
• 03.20.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.19.2026 - 144 Report of proposed sale of securities
• 03.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2026 - 144 Report of proposed sale of securities
• 03.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.27.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2026 - 4 Statement of changes in beneficial ownership of securities